Europe Radioactive Tracers Market Drivers and Forecasts by 2028
Europe Radioactive Tracers Market Forecast to 2028 - Regional Analysis by Test Type (PET, SPECT, and Others), End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others), Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], and Application (Oncology, Pulmonary, Neurology, Cardiology, and Others)
- Report Date : May 2023
- Report Code : TIPRE00029871
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 232
The Europe radioactive tracers market size is expected to grow from US$ 4,175.25 million in 2022 to US$ 11,005.25 million by 2028; it is estimated to record a CAGR of 17.5% during 2023–2028.
A radioactive tracer is a chemical compound in which one or more atoms are replaced by a radioisotope. Radiotracers can be used to study chemical reactions based on the monitoring of their radioactive decay. They are also used to visualize flow in techniques such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and computed radioactive particle tracking (CARPT).
The Europe radioactive tracer market is segmented on the basis of tracer type, end user, test type, application, and geography. Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The report offers insights and in-depth analysis of the Europe radioactive tracers market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the world's leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Radioactive Tracers Market: Strategic Insights
Market Size Value in US$ 4,175.25 million in 2022 Market Size Value by US$ 11,005.25 million by 2028 Growth rate CAGR of 17.5% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Radioactive Tracers Market: Strategic Insights
| Market Size Value in | US$ 4,175.25 million in 2022 |
| Market Size Value by | US$ 11,005.25 million by 2028 |
| Growth rate | CAGR of 17.5% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
New Initiatives for Radioactive Tracer R&D to Offer Opportunities for Europe Radioactive Tracers Market Growth During Forecast Period
The European Union Committee has taken various initiatives for boosting research & development activities in the field of radioactive tracers and radioisotopes. PRISMAP is a European medical radionuclide program that was started to provide access to novel radioisotopes of high purity grade for medical research. According to data provided under this program, out of the ~3,000 different radioisotopes synthesized by scientists in laboratories under European Union, only a handful are used regularly for medical procedures, mostly for imaging. Therefore, to increase the innovation and approval of these radioisotopes, the European Commission is planning to launch European Radioisotope Valley Initiative (ERVI) to maintain the region’s global leadership in the supply of medical radioisotopes and to help accelerate the development and introduction of new radioisotopes along with their production methods. Such a rise in the number of initiatives for boosting the supply of radioactive tracers for research purposes is expected to fuel the growth of the radioactive tracers market during the forecast period.
Many hospitals and research institutes focus on developing and using different radioactive tracers for the diagnosis of chronic diseases. Massachusetts General Hospital (MGH) is focused on using a new PET tracer [18F]3F4AP for the diagnosis of multiple sclerosis, Alzheimer’s disease, mild cognitive impairment, and traumatic brain injury. According to the National Library of Medicine (ClinicalTrials.gov), the use of [18F]3F4AP in the diagnosis of multiple sclerosis is in Phase 1 clinical trial, whereas the use of [18F]3F4AP for the diagnosis of Alzheimer’s disease, mild cognitive impairment, and traumatic brain injury is also in the Phase 1 trial. The ongoing research for the discovery of new radioactive tracers for the diagnosis of neurological disorders is anticipated to fuel the growth of the radioactive tracers market in the coming years.
Europe Radioactive Tracers Market-Test Type Insights
The Europe radioactive tracers market, based on test type, is segmented into PET, SPECT, and other test types. In 2022, the PET segment held the largest market share. The market for the same segment is expected to grow at the fastest CAGR in the coming years. PET provides quantitative information on the distribution of positron emitter-labeled radiopharmaceuticals (PET radiopharmaceuticals) in the body. PET imaging procedure involves the use of several expensive equipment, such as a cyclotron for radionuclide production, automated chemistry devices, purification instrumentation, and PET cameras. The advantages of PET over traditional radionuclide imaging techniques include higher spatial resolution and sensitivity, quantification of activity, and synthesizing physiologically useful tracers. PET uses small amounts of radioactive materials termed radiotracers, requiring a special camera and a computer to help evaluate the functioning of specific organs and tissues. By identifying bodily changes at the cellular level, PET may detect the early signs of disease before it is evident on other imaging tests. Nowadays, nearly all PET scans are performed in combination with CT scanners. The combined PET/CT scans provide images that locate the anatomic location of abnormal metabolic activity inside the body. The combined scans provide more accurate diagnoses than the two scans performed separately. Although the PET segment is expected to witness significant growth during the forecast period owing to several advantages, the high cost of PET scanners hinders its adoption in scanning diseases. Therefore, the Europe radioactive tracers market for the PET segment is expected to experience significant growth during the forecast period.
Europe Radioactive Tracers Market, by Test Type – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Impact of COVID-19 on Europe Radioactive Tracers Market
The COVID-19 pandemic has led to profound changes in hospital operations, including nuclear medicine (NM) practice across Europe. A literature search on PubMed covered COVID-19 studies published up until January 2021. As per the findings, the pandemic posed significant challenges for NM departments, and a reduction in the workforce was experienced in every center in Europe in 2020. NM departments introduced restriction measures to limit COVID-19 transmission, including rescheduling non-high-priority procedures. Also, some of the departments experienced delays in radioactive tracers supply or technical assistance amid this crisis. As a result, the pandemic resulted in a significant reduction in diagnostic NM procedures and a reduced level of care for patients affected by diseases other than COVID-19, such as cancer or acute cardiovascular disease. According to the results of the British Nuclear Medicine Society’s (BNMS) COVID-19 survey, ~97% of NM departments introduced procedures to limit SARS-CoV-2 transmission; at 68% of sites, standardized operating procedures were developed for running departments in pandemic situations.
However, new findings supporting innovations in the methods for COVID-19 diagnosis are expected to accelerate the growth of the radioactive tracers market in Europe. As per the research study by Chentao Jin et al., published in the European Journal of Nuclear Medicine and Molecular Imaging in May 2021, PET is expected to offer pathophysiological alternations of COVID-19 and facilitate the clinical management of patients.
Europe Radioactive Tracers Market – Market Segmentation
The Europe radioactive tracers market, based on test type, is segmented into PET, SPECT, and others. By end user, the market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The Europe radioactive tracers market, by tracer type, is segmented into Technetium-99m and Tc-97m, Iodine-13, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride and Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) and FDOPA (F-18), Phosphorus-32 and chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The Europe radioactive tracers market, by application, is segmented into oncology, pulmonary, neurology, cardiology, and others. Based on country, the Europe radioactive tracers market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Europe Radioactive Tracers Market – Company Profiles
- Rotem Industries Ltd.
- ABX Advanced Biochemical Compounds GmbH
- Invicro LLC.
- Cardinal Health
- Newcastle University
- Novartis
- Curium
- Blue Earth Diagnostics
- IBA Radiopharma Solutions
- General Electric Company
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type, End User, Tracer Type, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
As per test type, the positron emission tomography (PET) segment accounted to grow at the fastest CAGR in the market during the forecast period.
The Europe radioactive tracer market is expected to be valued at US$ 11,005.25 million in 2028.
The Europe radioactive tracer market majorly consists of the players such as Rotem Industries Ltd., ABX Advanced Biochemical Compounds GmbH, Invicro LLC., Cardinal Health, Newcastle University, Novartis, Curium, Blue Earth Diagnostics, IBA Radiopharma Solutions, among others.
The single-photon emission computed tomography (SPECT Scan) segment held the largest revenue share of the market in 2022.
A radioactive tracer is a chemical compound in which one or more atoms have been replaced by a radioisotope. Through monitoring its radioactive decay, a radiotracer can be used to study chemical reactions. Through different technologies, they are also used to visualize flow, including Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Computed Radioactive Particle Tracking (CARPT).
The Europe radioactive tracer market was valued at US$ 4,175.25 million in 2022.
The factors driving the Europe radioactive tracer market growth, includes rising prevalence of chronic diseases and increased use of nuclear imaging techniques. However, the short shelf-life of radioactive tracers and availability of substitutes to nuclear diagnostic imaging procedures are hampering the Europe radioactive tracer market growth.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Radioactive Tracer Market – by Test Type
1.3.2 Europe Radioactive Tracer Market – By End User
1.3.3 Europe Radioactive Tracer Market – By Tracer Type
1.3.4 Europe Radioactive Tracer Market – By Application
1.3.5 Europe Radioactive Tracer Market – By Country
2. Europe Radioactive Tracer Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Radioactive Tracer Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts’ Opinion
5. Radioactive Tracer Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Increased Use Of Nuclear Imaging Techniques
5.2 Market Restraints
5.2.1 Short Shelf-Life of Radioactive Tracers
5.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
5.3 Market Opportunities
5.3.1 New Initiatives for Radioactive Tracer R&D
5.4 Future Trends
5.4.1 Use of Radioactive Tracers in Cancer Diagnosis
5.5 Impact Analysis
6. Europe Radioactive Tracer Market Analysis
6.1 Europe Radioactive Tracer Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in Radioactive Tracer Market
7. Europe Radioactive Tracer Market Analysis – by Test Type
7.1 Overview
7.2 PET
7.2.1 Overview
7.2.2 PET: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
7.3 SPECT
7.3.1 Overview
7.3.2 SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Radioactive Tracer Market Analysis – by End User
8.1 Overview
8.2 Hospitals and Clinics
8.2.1 Overview
8.2.2 Hospitals and Clinics: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Diagnostic Centers
8.3.1 Overview
8.3.2 Diagnostic Center: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Academic and Research Institute
8.4.1 Overview
8.4.2 Academic and Research Institute: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Radioactive Tracer Market Analysis – by Tracer Type
9.1 Overview
9.2 Technetium-99m And Tc-97m
9.2.1 Overview
9.2.2 Technetium-99m And Tc-97m: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Technetium-99m And Tc-97m: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.3 IODINE-131
9.3.1 Overview
9.3.2 IODINE-131: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 IODINE-13: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.4 IRON-59
9.4.1 Overview
9.4.2 IRON-59: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 IRON-59: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.5 LUTETIUM-171
9.5.1 Overview
9.5.2 LUTETIUM-171: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 LUTETIUM-171: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.6 Rubidium (Rb-82) Chloride and Ammonia (N-13)
9.6.1 Overview
9.6.2 Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.6.3 Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.7 Scandium-46
9.7.1 Overview
9.7.2 Scandium-46: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.7.3 Scandium-46: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.8 Seaborgium-269
9.8.1 Overview
9.8.2 Seaborgium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.8.3 Seaborgium-269: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.9 Hassium-269
9.9.1 Overview
9.9.2 Hassium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.9.3 Hassium-269: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.10 Gallium Citrate Ga 67
9.10.1 Overview
9.10.2 Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.10.3 Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.11 Prostate-specific membrane antigen (PSMA) (Ga-68)
9.11.1 Overview
9.11.2 Prostate-specific membrane antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.11.3 Prostate-specific membrane antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.12 FDDNP (F-18) and FDOPA (F-18)
9.12.1 Overview
9.12.2 FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.12.3 FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.13 Phosphorus-32 and chromium-51
9.13.1 Overview
9.13.2 Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.13.3 Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market – Volume and Forecast to 2028
9.14 Thallium-201
9.14.1 Overview
9.14.2 Thallium-201: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
9.14.3 Thallium-201: Europe Radioactive Tracer Market – Volume and Forecast to 20281
9.15 F-18 FDG2
9.15.1 Overview2
9.15.2 F-18 FDG: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
9.15.3 F-18 FDG: Europe Radioactive Tracer Market – Volume and Forecast to 20284
9.16 F-18 FAPI5
9.16.1 Overview5
9.16.2 F-18 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
9.16.3 F-18 FAPI: Europe Radioactive Tracer Market – Volume and Forecast to 20286
9.17 GA-68 FAPI7
9.17.1 Overview7
9.17.2 GA-68 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)7
9.17.3 GA-68 FAPI: Europe Radioactive Tracer Market – Volume and Forecast to 20288
9.18 F-18 PSMA9
9.18.1 Overview9
9.18.2 F-18 PSMA: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)9
9.18.3 F-18 PSMA: Europe Radioactive Tracer Market – Volume and Forecast to 20280
9.19 Ga-68 (DOTATOC/DOTANOC/ DOTATATE)1
9.19.1 Overview1
9.19.2 GA-68 (DOTATOC/DOTANOC/ DOTATATE) : Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
9.19.3 GA-68 DOTATOC/DOTANOC/ DOTATATE): Europe Radioactive Tracer Market – Volume and Forecast to 20283
9.20 Others Tracer4
9.20.1 Overview4
9.20.2 Other Tracer Element: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)4
10. Europe Radioactive Tracer Market Analysis – by Application6
10.1 Overview6
10.2 Oncology7
10.2.1 Overview7
10.2.2 Oncology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)7
10.3 Pulmonary9
10.3.1 Overview9
10.3.2 Pulmonary: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)9
10.4 Neurology1
10.4.1 Overview1
10.4.2 Neurology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)1
10.5 Cardiology3
10.5.1 Overview3
10.5.2 Cardiology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)3
10.6 Others5
10.6.1 Overview5
10.6.2 Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
11. Europe Radioactive Tracer Market7
11.1 Europe7
11.1.1 Overview7
11.1.2 Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)8
11.1.3 Europe Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)9
11.1.4 Europe Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)9
11.1.5 Europe Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)0
11.1.6 Europe Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)2
11.1.7 Europe Radioactive Tracer Market, by Application, 2019–2028 (US$ Million)3
11.1.8 Europe Radioactive Tracer Market, by Country, 2021 & 2028 (%)4
11.1.8.1 Germany5
11.1.8.1.1 Overview5
11.1.8.1.2 Germany Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
11.1.8.1.3 Germany Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)7
11.1.8.1.4 Germany Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)7
11.1.8.1.5 Germany Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)8
11.1.8.1.6 Germany Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)9
11.1.8.1.7 Germany Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)1
11.1.8.2 United Kingdom2
11.1.8.2.1 Overview2
11.1.8.2.2 United Kingdom Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
11.1.8.2.3 United Kingdom Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)3
11.1.8.2.4 United Kingdom Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)4
11.1.8.2.5 United Kingdom Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)5
11.1.8.2.6 United Kingdom Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)6
11.1.8.2.7 United Kingdom Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)7
11.1.8.3 France8
11.1.8.3.1 Overview8
11.1.8.3.2 France Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)8
11.1.8.3.3 France Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)9
11.1.8.3.4 France Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)0
11.1.8.3.5 France Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)1
11.1.8.3.6 France Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)2
11.1.8.3.7 France Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)3
11.1.8.4 Italy4
11.1.8.4.1 Overview4
11.1.8.4.2 Italy Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
11.1.8.4.3 Italy Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)6
11.1.8.4.4 Italy Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)6
11.1.8.4.5 Italy Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)7
11.1.8.4.6 Italy Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)8
11.1.8.4.7 Italy Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)0
11.1.8.5 Spain1
11.1.8.5.1 Overview1
11.1.8.5.2 Spain Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)1
11.1.8.5.3 Spain Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)2
11.1.8.5.4 Spain Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)3
11.1.8.5.5 Spain Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)4
11.1.8.5.6 Spain Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)5
11.1.8.5.7 Spain Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)7
11.1.8.6 Rest of Europe8
11.1.8.6.1 Overview8
11.1.8.6.2 Rest of Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)8
11.1.8.6.3 Rest of Europe Radioactive Tracer Market, by Test Type, 2019–2028 (US$ Million)9
11.1.8.6.4 Rest of Europe Radioactive Tracer Market, by End User, 2019–2028 (US$ Million)0
11.1.8.6.5 Rest of Europe Radioactive Tracer Market, by Tracer Type, 2019–2028 (US$ Million)1
11.1.8.6.6 Rest of Europe Radioactive Tracer Market, by Tracer Type, 2019–2028 (Unit)2
11.1.8.6.7 Rest of Europe Radioactive Tracer Market, by Application Type, 2019–2028 (US$ Million)3
12. Europe Radioactive Tracer Market: Impact Assessment of COVID-19 Pandemic5
12.1 Impact Analysis of COVID-19 Pandemic on Europe Radioactive Tracer Market5
13. Europe Radioactive Tracers Market–Industry Landscape7
13.1 Overview7
13.2 Growth Strategies in the Europe Radioactive Tracers Market (%)8
13.3 Inorganic Developments9
13.3.1 Overview9
13.4 Organic Developments0
13.4.1 Overview0
14. Company Profiles2
14.1 Rotem Industries Ltd2
14.1.1 Key Facts2
14.1.2 Business Description2
14.1.3 Products and Services3
14.1.4 Financial Overview3
14.1.5 SWOT Analysis4
14.1.6 Key Developments4
14.2 ABX advanced biochemical compounds GmbH5
14.2.1 Key Facts5
14.2.2 Business Description5
14.2.3 Products and Services6
14.2.4 Financial Overview7
14.2.5 SWOT Analysis8
14.2.6 Key Developments8
14.3 Invicro LLC9
14.3.1 Key Facts9
14.3.2 Business Description9
14.3.3 Products and Services0
14.3.4 Financial Overview0
14.3.5 SWOT Analysis1
14.3.6 Key Developments2
14.4 Cardinal Health Inc3
14.4.1 Key Facts3
14.4.2 Business Description3
14.4.3 Products and Services4
14.4.4 Financial Overview5
14.4.5 SWOT Analysis7
14.4.6 Key Developments7
14.5 Newcastle University8
14.5.1 Key Facts8
14.5.2 Business Description8
14.5.3 Products and Services9
14.5.4 Financial Overview0
14.5.5 SWOT Analysis1
14.5.6 Key Developments1
14.6 Novartis AG2
14.6.1 Key Facts2
14.6.2 Business Description2
14.6.3 Products and Services3
14.6.4 Financial Overview4
14.6.5 SWOT Analysis6
14.6.6 Key Developments7
14.7 Curium8
14.7.1 Key Facts8
14.7.2 Business Description8
14.7.3 Products and Services9
14.7.4 Financial Overview9
14.7.5 SWOT Analysis0
14.7.6 Key Developments1
14.8 Blue Earth Diagnostics Limited2
14.8.1 Key Facts2
14.8.2 Business Description2
14.8.3 Products and Services3
14.8.4 Financial Overview3
14.8.5 SWOT Analysis4
14.8.6 Key Developments4
14.9 General Electric Co5
14.9.1 Key Facts5
14.9.2 Business Description5
14.9.3 Products and Services7
14.9.4 Financial Overview8
14.9.5 SWOT Analysis0
14.9.6 Key Developments1
14.10 IBA Radiopharma Solutions2
14.10.1 Key Facts2
14.10.2 Business Description2
14.10.3 Products and Services3
14.10.4 Financial Overview4
14.10.5 SWOT Analysis6
14.10.6 Key Developments7
15. Appendix8
15.1 About The Insight Partners8
15.2 Glossary of Terms9
LIST OF TABLES
Table 1. Principal Radionuclides Used in Radioactive Tracers
Table 2. Europe Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)9
Table 3. Europe Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)9
Table 4. Europe Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)0
Table 5. Europe Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)2
Table 6. Europe Radioactive Tracer Market, by Application – Revenue and Forecast to 2028 (US$ Million)3
Table 7. Germany Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)7
Table 8. Germany Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)7
Table 9. Germany Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)8
Table 10. Germany Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)9
Table 11. Germany Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)1
Table 12. United Kingdom Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)3
Table 13. United Kingdom Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)4
Table 14. United Kingdom Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)5
Table 15. United Kingdom Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)6
Table 16. United Kingdom Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)7
Table 17. France Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)9
Table 18. France Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 19. France Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)1
Table 20. France Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)2
Table 21. France Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)3
Table 22. Italy Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)6
Table 23. Italy Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)6
Table 24. Italy Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)7
Table 25. Italy Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)8
Table 26. Italy Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)0
Table 27. Spain Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)2
Table 28. Spain Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)3
Table 29. Spain Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)4
Table 30. Spain Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)5
Table 31. Spain Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)7
Table 32. Rest of Europe Radioactive Tracer Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)9
Table 33. Rest of Europe Radioactive Tracer Market, by End User – Revenue and Forecast to 2028 (US$ Million)0
Table 34. Rest of Europe Radioactive Tracer Market, by Tracer Type – Revenue and Forecast to 2028 (US$ Million)1
Table 35. Rest of Europe Radioactive Tracer Market, by Tracer Type – Volume and Forecast to 2028 (Unit)2
Table 36. Rest of Europe Radioactive Tracer Market, by Application Type – Revenue and Forecast to 2028 (US$ Million)3
Table 37. Inorganic Developments in the Europe radioactive tracers Market9
Table 38. Organic Developments in the Europe radioactive tracers Market0
Table 39. Glossary of Terms9
LIST OF FIGURES
Figure 1. Radioactive Tracer Market Segmentation
Figure 2. Radioactive Tracer Market Segmentation, by Country
Figure 3. Europe Radioactive Tracer Market Overview
Figure 4. SPECT Held Largest Share of Test Type Segment in Radioactive Tracer Market
Figure 5. Europe Radioactive Tracer Market – Leading Country Markets (US$ Million)
Figure 6. Europe Radioactive Tracer Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Procedure Trays Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Radioactive Tracer Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. Europe Radioactive Tracer Market, by Test Type, 2021 & 2028 (%)
Figure 11. PET: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. SPECT: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Radioactive Tracer Market, by End User, 2021 & 2028 (%)
Figure 15. Hospitals and Clinics: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Diagnostic Center: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Academic and Research Institute: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Radioactive Tracer Market, by Tracer Type, 2021 & 2028 (%)
Figure 20. Technetium-99m And Tc-97m: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Technetium-99m And Tc-97m: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 22. IODINE-13: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. IODINE-13: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 24. IRON-59: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. IRON-59: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 26. LUTETIUM-171: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. LUTETIUM-171: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 28. Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rubidium (Rb-82) Chloride and Ammonia (N-13): Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 30. Scandium-46: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Scandium-46: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 32. Seaborgium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Seaborgium-269: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 34. Hassium-269: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Hassium-269: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 36. Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Gallium Citrate Ga 67: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 38. Prostate-specific membrane antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Prostate-Specific Membrane Antigen (PSMA) (Ga-68): Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 40. FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. FDDNP (F-18) and FDOPA (F-18): Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 42. Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Phosphorus-32 and chromium-51: Europe Radioactive Tracer Market – Volume and Forecast to 2028
Figure 44. Thallium-201: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 45. Thallium-201: Europe Radioactive Tracer Market – Volume and Forecast to 20281
Figure 46. F-18 FDG: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 47. F-18 FDG: Europe Radioactive Tracer Market – Volume and Forecast to 20284
Figure 48. F-18 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 49. F-18 FAPI: Europe Radioactive Tracer Market – Volume and Forecast to 20286
Figure 50. GA-68 FAPI: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)7
Figure 51. GA-68 FAPI: Europe Radioactive Tracer Market – Volume and Forecast to 20288
Figure 52. F-18 PSMA: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 53. F-18 PSMA: Europe Radioactive Tracer Market – Volume and Forecast to 20280
Figure 54. GA-68 DOTATOC/DOTANOC/ DOTATATE): Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 55. GA-68 DOTATOC/DOTANOC/ DOTATATE): Europe Radioactive Tracer Market – Volume and Forecast to 20283
Figure 56. Other Tracer Element: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 57. Europe Radioactive Tracer Market, by Application, 2021 & 2028 (%)6
Figure 58. Oncology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 59. Pulmonary: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)0
Figure 60. Neurology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 61. Cardiology: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)4
Figure 62. Others: Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)6
Figure 63. Europe Radioactive Tracer Market, by Key Country – Revenue (2021) (US$ Million)7
Figure 64. Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)8
Figure 65. Europe Radioactive Tracer Market, by Country, 2021 & 2028 (%)4
Figure 66. Germany Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)6
Figure 67. United Kingdom Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)3
Figure 68. France Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 69. Italy Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)5
Figure 70. Spain Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)2
Figure 71. Rest of Europe Radioactive Tracer Market – Revenue and Forecast to 2028 (US$ Million)9
Figure 72. Impact of COVID-19 Pandemic on Europe Country Markets6
Figure 73. Growth Strategies in the Europe Radioactive Tracers Market (%)8
The List of Companies - Europe Radioactive Tracer Market
- Rotem Industries Ltd
- ABX advanced biochemical compounds GmbH
- Invicro LLC
- Cardinal Health Inc
- Newcastle University
- Novartis AG
- Curium
- Blue Earth Diagnostics Limited
- General Electric Co
- IBA Radiopharma Solutions
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
May 2023
Wheelchair and Mobility Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
May 2023
Cystoscopy and Ureteroscopy Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
May 2023
Cancer Drugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography
May 2023
Walking Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Canes, Crutches, Walkers, Rollators, and Others), Age Group (Adults and Pediatric), Application (Neurologically Impaired, Handicap Patients, and Others), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
May 2023
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
May 2023
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
May 2023
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
May 2023
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For